These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 7728354)
1. Hypoxanthine-guanine phosphoribosyltransferase as a therapeutic target in protozoal infections. Ullman B; Carter D Infect Agents Dis; 1995 Mar; 4(1):29-40. PubMed ID: 7728354 [TBL] [Abstract][Full Text] [Related]
2. Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates. Ullman B; Carter D Int J Parasitol; 1997 Feb; 27(2):203-13. PubMed ID: 9088991 [TBL] [Abstract][Full Text] [Related]
3. Development of a bacterial screen for novel hypoxanthine-guanine phosphoribosyltransferase substrates. Shivashankar K; Subbayya IN; Balaram H J Mol Microbiol Biotechnol; 2001 Oct; 3(4):557-62. PubMed ID: 11545274 [TBL] [Abstract][Full Text] [Related]
4. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein. Munagala NR; Wang CC Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428 [TBL] [Abstract][Full Text] [Related]
6. Hypoxanthine-Guanine Phosphoribosyltransferase Is Dispensable for Mycobacterium smegmatis Viability. Knejzlík Z; Herkommerová K; Hocková D; Pichová I J Bacteriol; 2020 Feb; 202(5):. PubMed ID: 31818925 [TBL] [Abstract][Full Text] [Related]
7. Rational design of novel antimicrobials: blocking purine salvage in a parasitic protozoan. Somoza JR; Skillman AG; Munagala NR; Oshiro CM; Knegtel RM; Mpoke S; Fletterick RJ; Kuntz ID; Wang CC Biochemistry; 1998 Apr; 37(16):5344-8. PubMed ID: 9548915 [TBL] [Abstract][Full Text] [Related]
8. Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy. de Koning HP; Bridges DJ; Burchmore RJ FEMS Microbiol Rev; 2005 Nov; 29(5):987-1020. PubMed ID: 16040150 [TBL] [Abstract][Full Text] [Related]
9. Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma brucei. Allen TE; Ullman B Nucleic Acids Res; 1993 Nov; 21(23):5431-8. PubMed ID: 8265360 [TBL] [Abstract][Full Text] [Related]
10. Unusual substrate specificity of a chimeric hypoxanthine-guanine phosphoribosyltransferase containing segments from the Plasmodium falciparum and human enzymes. Sujay Subbayya IN; Sukumaran S; Shivashankar K; Balaram H Biochem Biophys Res Commun; 2000 Jun; 272(2):596-602. PubMed ID: 10833458 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of Thermoanaerobacter tengcongensis hypoxanthine-guanine phosphoribosyl transferase L160I mutant--insights into inhibitor design. Chen Q; You D; Liang Y; Su X; Gu X; Luo M; Zheng X FEBS J; 2007 Sep; 274(17):4408-15. PubMed ID: 17662107 [TBL] [Abstract][Full Text] [Related]
15. [Cloning, expression and characterization of the hypoxanthine-guanine phosphoribosyltransferase mutants from T. tengcongensis]. You DL; Qu H; Chen Q; Xing Y; Gu XC; Luo M Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):853-8. PubMed ID: 12958660 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents. Krečmerová M; Dračínský M; Hocková D; Holý A; Keough DT; Guddat LW Bioorg Med Chem; 2012 Feb; 20(3):1222-30. PubMed ID: 22249123 [TBL] [Abstract][Full Text] [Related]
17. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation. Hammarton TC; Mottram JC; Doerig C Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704 [TBL] [Abstract][Full Text] [Related]
18. Antiparasitic chemotherapy: tinkering with the purine salvage pathway. Datta AK; Datta R; Sen B Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics. Keough DT; Hocková D; Holý A; Naesens LM; Skinner-Adams TS; Jersey Jd; Guddat LW J Med Chem; 2009 Jul; 52(14):4391-9. PubMed ID: 19527031 [TBL] [Abstract][Full Text] [Related]
20. Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases. Keough DT; Skinner-Adams T; Jones MK; Ng AL; Brereton IM; Guddat LW; de Jersey J J Med Chem; 2006 Dec; 49(25):7479-86. PubMed ID: 17149876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]